TKG Therapeutics, Inc.
PrivateLast Round
Seed
Jan 31, 2024
Est. Valuation
$2.04M
Total Funding Raised
$1.02M
Company Overview
TKG Therapeutics, Inc. is a biotechnology company that develops nucleic acid-based cancer immunotherapies and proprietary immersion solid-phase synthesis technologies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TKG Therapeutics, Inc. Comparables
Compare TKG Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| e-NA Biotec Inc. | 78% | |
| Liid Pharmaceuticals, Inc. | 72% | |
| OncoNano Medicine | 72% | |
TKG Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 31, 2024 |
TKG Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| UntroD Capital Japan Inc. | Seed |
TKG Therapeutics, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about TKG Therapeutics, Inc.'s valuation, stock price, and market status.